Wednesday - April 24, 2024

Category Archives: Finance

HER2+ Gastric Cancer Pipeline Assessment, 2023 Updates | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the HER2+ Gastric Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), … Continue reading →

Head and Neck Cancer Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Advaxis, Alkermes, ALX Oncology, AstraZeneca, Bayer, BioAtla, Celldex

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 150+ key pharma and biotech companies are working on 150+ pipeline drugs in the Head and Neck Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action … Continue reading →

Prader-Willi Syndrome Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | OptiNose, Helsinn, ConSynance, GLWL Research, Acadia Pharmaceuticals

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 18+ key pharma and biotech companies are working on 18+ pipeline drugs in the Prader-Willi Syndrome therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and … Continue reading →

Opioid Use Disorder Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examine DelveInsight | Key Players – Indivior, Alkermes, Orexo AB, Mallinckrodt, Braeburn Pharmaceutical

Delveinsight Business Research LLP The Opioid Use Disorder Market size was USD ~1970 million in 2022, which is expected to increase by 2032. As per DelveInsight, the Opioid Use Disorder Market is anticipated to evolve immensely in the coming years … Continue reading →

Ornithine Transcarbamylase Deficiency (OTC Deficiency) Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies – Arcturus, Ultragenyx

Delveinsight Business Research LLP As per DelveInsight, the Ornithine Transcarbamylase Deficiency Market is anticipated to evolve immensely in the coming years owing to the improvement in the research and development activities so that the market will comprise of efficient treatment … Continue reading →